Freenome, Inc. Shareholders' Equity
Freenome, Inc. (FRNM) had Shareholders' Equity of -$6.30 million as of 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-18
- 2026-06-30: Stockholders' Equity Attributable to Parent -$6.30M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$5.66M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$4.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$3.12M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$6.30M S-1 · filed 2026-08-18 |
| 2026-03-31 | -$5.66M S-1 · filed 2026-08-18 |
| 2025-12-31 | -$4.80M S-1 · filed 2026-08-18 |
| 2025-09-30 | -$3.12M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$2.27M S-1 · filed 2026-08-18 |
| 2025-03-31 | -$2.37M S-1 · filed 2026-08-18 |
| 2024-12-31 | -$2.12M S-1 · filed 2026-08-18 |
| 2024-09-30 | -$1.94M 10-Q · filed 2025-11-13 |
| 2024-06-30 | -$1.74M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $9.60K 10-Q · filed 2025-11-13 |
| 2024-03-21 | $0.00 S-1 · filed 2026-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |